NoileImmunes tech gets $315m vote of confidence to tackle solid tumors

Noile-Immune’s tech gets $315m vote of confidence to tackle solid tumors

Noile-Immune signs its second high profile agreement, the latest with Adaptimmune to combine the companiesâ technology to pre-clinical studies for the treatment of cancer.

More From BioPortfolio on "Noile-Immune’s tech gets $315m vote of confidence to tackle solid tumors"